Published in Hepatitis Weekly, March 23rd, 1998
"The findings of this pilot study indicate that long-term treatment with low doses of interferon does not lead to eradication or suppression of serum HCV RNA in HCV carriers with persistently normal ALT values," Angelo Sangiovanni and colleagues wrote ("Interferon Alpha Treatment of HCV RNA Carriers with Persistently Normal Transaminase Levels: A Pilot Randomized Controlled Study," Hepatology, March 1998;27(3):853-856).
Certain patients with serum markers of HCV replication (HCV RNA) have...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.